Biogen Inc (BIIB)

[Cbdpotential]

Great question, in my opinion, Anavex is either holding its cards tight in an attempt to grow their pipeline into a major BP without having to give up pennies on the dollars, or current BP’s are simply waiting (possibly in fear) for the data from Anavex’s current trials. Or of course, Anavex doesn’t have “the goods”.

Biogen has/is still testing anavex’s lead drug candidate Anavex 2-73. It’s possible Biogen is, too, holding some of the same cards behind closed doors.

One thing is for sure, 2019 seems to have a very different feel in bio land.

It’s time to embrace new, and many, perspectives.

All jmho of course.